Showing results (1321-1330 of 1,833) with videos related to
Sort By:
Pageof 184
Signal Transduction and Targeted Therapy|April 19, 2026
Targeting ATP11B-YAP axis repairs mitochondrial function and inhibits neuronal ferroptosis to attenuate age-related cognitive declineWenxin Qi, Qian Liu, Naijun Dong, et al.Signal Transduction and Targeted Therapy|May 6, 2026
Sintilimab (PD-1 inhibitor) plus lenvatinib as conversion therapy followed by sequential surgery (SILENSES) for advanced unresectable hepatocellular carcinoma: a phase II, expansion trialShichun Lu, Wenwen Zhang, Junfeng Li, et al.Signal Transduction and Targeted Therapy|April 24, 2026
Tumor-derived DNA drives cancer-associated anemia by promoting reticulocyte clearanceTing Yuan, Xuebing Liu, Yucui Wu, et al.Signal Transduction and Targeted Therapy|April 22, 2026
Temporal assessment of behavior in Parkinson's visual hallucinations via a multidimensional analysis strategyQuan-Xin Zhang, Yi-Xuan Zhang, Chen-Chen Jiang, et al.Signal Transduction and Targeted Therapy|April 26, 2026
Abexinostat, a histone deacetylases inhibitor, for patients with relapsed or refractory follicular lymphoma: a multi-center, single-arm phase 2 studyLin Gui, Haifeng Liu, Huaqing Wang, et al.Signal Transduction and Targeted Therapy|April 22, 2026
Macrophage metabolic reprogramming by vanadium released from glucose-responsive bio-gel accelerates diabetic wound repairJiangfeng Li, Zheng Li, Lili Han, et al.Signal Transduction and Targeted Therapy|April 15, 2026
Endoplasmic reticulum stress in disease pathogenesis: its implications for therapySiyu Wei, Nan Zhang, Hao Zhang, et al.Signal Transduction and Targeted Therapy|April 12, 2026
Deutenzalutamide, a novel androgen receptor inhibitor, after progression on docetaxel and abiraterone in metastatic castration-resistant prostate cancer: results from the randomized phase III HC-1119-04 trialJunlong Wu, Xinghai Li, Chengyuan Gu, et al.Signal Transduction and Targeted Therapy|May 7, 2026
Acute hemodynamic effects of TPN171H in pulmonary arterial hypertension: a randomized, controlled, phase 2a trialYu-Ping Zhou, Lu-Hong Qiu, Wei Ma, et al.Signal Transduction and Targeted Therapy|August 28, 2022
Signaling pathways in obesity: mechanisms and therapeutic interventionsXue Wen, Bohan Zhang, Beiyi Wu, et al.Pageof 184